• Products
• Consumer Healthcare
• Cosmetics & Fragrances
• Foodstuffs & Confectionary products
• Paper Products
• Personal Care & Household
• Pharmaceuticals

alli is the first and only non-prescription weight loss aid to receive an EU license from the European Commission. It belongs to GlaxoSmithKline, a leading pharmaceutical company that helps people to do more, feel better and live longer. alli has been approved for use by overweight adults with a BMI of 28 Kg/m² or over and should be used with a reduced-calorie, lower-fat diet. alli helps people lose 50 per cent more weight than diet alone.  

 We introduced alli in Pharmacies of Cyprus market at the beginning of October 2009. Two launch events took place in Nicosia    and Limassol for Pharmacists as well as a Press Conference.

 The presentations during the events were conducted by distinguished guests from Greece. The General Manager of GSK Consumer Healthcare of Greece/Cyprus/Malta, Mr. Constantinos Vossos, made an introductory speech. Then, Dr. George Panotopoulos, GP/Nutritionist, Administrator of Department of Obesity, Metabolism & Nutrition of ‘ΥΓΕΙΑ’ hospital in Athens, presented interesting data on obesity & orlistat. Mrs. Sofia Nasiou, Business Development Manager for Cyprus, presented all information around alli.